Risa Stack joined Kleiner Perkins Caufield & Byers in 2003. Risa
specializes in the development of life science companies. She was the
founding CEO and is currently a board member of several companies
including CardioDx, Nodality, and an incubation in the personalized
medicine area. She is a board observer at Codon Devices, Xdx, Orexigen
(OREX), Tethys, and Pacific Biosciences.Prior
to joining KPCB, Risa was a Principal at J.P. Morgan Partner...
more
Risa Stack joined Kleiner Perkins Caufield & Byers in 2003. Risa
specializes in the development of life science companies. She was the
founding CEO and is currently a board member of several companies
including CardioDx, Nodality, and an incubation in the personalized
medicine area. She is a board observer at Codon Devices, Xdx, Orexigen
(OREX), Tethys, and Pacific Biosciences.
Prior
to joining KPCB, Risa was a Principal at J.P. Morgan Partners in the
life science practice for 6 years. While at J.P. Morgan Partners she
sponsored a series of investments including Acurian, AlgoRx (now
Anesiva), Connetics, Diatide, Ilex Oncology, Illumina, Praecis
Pharmaceuticals and Triangle Pharmaceuticals.
Prior to working
in the venture capital industry, Risa worked as a Derivative Specialist
on the Chicago Board of Trade where she traded futures and options on
government securities. As an intern at ARCH Development Corporation she
participated in the development of several companies based on the
research of University of Chicago scientists. At Abbott Laboratories,
Risa worked to develop a new Hepatitis C assay system and researched
new procedures for evaluating patient samples for HIV and Hepatitis B.
Risa
received her B.S. in Genetics and Development with distinction from the
University of Illinois and her Ph.D. in Immunology from the University
of Chicago. She was also a member of the second class of Kauffman
Fellows.
Risa was named as one of the 100 Most Influential Women in Business by the San Francisco Business Times in 2004.
less
